CEO Tord Lendau resigns from Artimplant

Tord Lendau resigns as CEO of private reasons. Recruitment of a new CEO has been initiated.

During the last four years Artimplant has been transformed from a research company to a product development and marketing company. Today the company has six licensing agreements and one distribution agreement with three global partners and products available on the market, both within orthopedics and odontology. “It is time for a new challenge. I have had the opportunity to work with Artimplant during a dynamic period and am proud that Artimplant today has partners, regulatory approvals, cash, a strong development department and a stronger market position compared to when I joined in 2002.” says Tord Lendau